LLY

1,059.99

+0.61%↑

JNJ

209.07

-0.56%↓

ABBV

224.99

-0.37%↓

UNH

328.51

-1.77%↓

AZN

90.74

-0.29%↓

LLY

1,059.99

+0.61%↑

JNJ

209.07

-0.56%↓

ABBV

224.99

-0.37%↓

UNH

328.51

-1.77%↓

AZN

90.74

-0.29%↓

LLY

1,059.99

+0.61%↑

JNJ

209.07

-0.56%↓

ABBV

224.99

-0.37%↓

UNH

328.51

-1.77%↓

AZN

90.74

-0.29%↓

LLY

1,059.99

+0.61%↑

JNJ

209.07

-0.56%↓

ABBV

224.99

-0.37%↓

UNH

328.51

-1.77%↓

AZN

90.74

-0.29%↓

LLY

1,059.99

+0.61%↑

JNJ

209.07

-0.56%↓

ABBV

224.99

-0.37%↓

UNH

328.51

-1.77%↓

AZN

90.74

-0.29%↓

Search

Quanterix Corp

Deschisă

SectorSănătate

6.83 -5.27

Rezumat

Modificarea prețului

24h

Curent

Minim

6.87

Maxim

7.28

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

-18.48% downside

Statistici piață

By TradingEconomics

Capitalizare de piață

108M

346M

Deschiderea anterioară

12.1

Închiderea anterioară

6.83

Sentimentul știrilor

By Acuity

50%

50%

159 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 dec. 2025, 23:50 UTC

Acțiuni populare

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

17 dec. 2025, 23:20 UTC

Câștiguri

Correction to Micron Logs Sales Jump Article

17 dec. 2025, 23:07 UTC

Câștiguri

Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply -- Update

17 dec. 2025, 21:37 UTC

Câștiguri

Micron Technology 1Q Sales Jump 57%, Led By Memory Growth

17 dec. 2025, 23:53 UTC

Market Talk

Gold Edges Higher, Supported by Some Tailwinds -- Market Talk

17 dec. 2025, 23:43 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

17 dec. 2025, 23:06 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Transaction Expected to Be Closed in 2H of Calendar Year 2026

17 dec. 2025, 23:05 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Currently No Plans of Issuing New Shares in Asahi

17 dec. 2025, 23:04 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Funds to Be Provided Via Borrowings From Financial Institutions or Cash on Hand

17 dec. 2025, 23:03 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Acquisition of 53.68% Stake in UDV (Kenya) is $646M on Equity Value Basis

17 dec. 2025, 23:02 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Acquisition of 100% Stake in Diageo Kenya is $2.354B on Equity Value Basis

17 dec. 2025, 22:59 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Deal Part of Strategy Under Medium- to Long-Term Management Policy

17 dec. 2025, 22:57 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: To Indirectly Acquire 65.00% Stake in East African Breweries PLC

17 dec. 2025, 22:56 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Stakes Acquired From Two Subsidiaries of Diageo Plc

17 dec. 2025, 22:55 UTC

Achiziții, Fuziuni, Preluări

Asahi Group Holdings: To Acquire 100% Stake in Diageo Kenya Ltd., 53.68% Stake in UVD (Kenya) Ltd.

17 dec. 2025, 22:49 UTC

Market Talk

Sandfire Resources Production Pipeline Strength Questioned -- Market Talk

17 dec. 2025, 21:58 UTC

Câștiguri

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 dec. 2025, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

17 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 dec. 2025, 21:46 UTC

Câștiguri

Salesforce and Other AI Stocks That Can Catch Up to the Pack -- Barrons.com

17 dec. 2025, 21:20 UTC

Câștiguri

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 dec. 2025, 21:10 UTC

Câștiguri

Micron Beats Earnings. The Stock Is Rising. -- Barrons.com

17 dec. 2025, 21:05 UTC

Câștiguri

Micron Technology Anticipates Business Performance to Continue Strengthening Through FY26

17 dec. 2025, 21:04 UTC

Câștiguri

Micron Technology: 2Q Outlook Reflects Substantial Records Across Rev, Gross Margin, EPS and Free Cash Flow >MU

17 dec. 2025, 21:04 UTC

Câștiguri

Micron Technology Sees 2Q Oper Expenses $1.56B, Plus or Minus $20M >MU

17 dec. 2025, 21:03 UTC

Câștiguri

Micron Technology Sees 2Q Adj EPS $8.42, Plus or Minus 20c >MU

17 dec. 2025, 21:03 UTC

Câștiguri

Micron Technology Sees 2Q EPS $8.19, Plus or Minus 20c >MU

17 dec. 2025, 21:03 UTC

Câștiguri

Micron Technology Sees 2Q Revenue $18.7B, Plus or Minus $400M >MU

17 dec. 2025, 21:02 UTC

Câștiguri

Micron Technology 1Q Operating Cash Flow $8.41 B >MU

17 dec. 2025, 21:01 UTC

Câștiguri

Micron Technology 1Q Rev $13.64B >MU

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

-18.48% jos

Prognoză pe 12 luni

Medie 6 USD  -18.48%

Maxim 7 USD

Minim 5 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

159 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat